BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 14962060)

  • 1. Indole-based analogs of melatonin: in vitro antioxidant and cytoprotective activities.
    Mor M; Silva C; Vacondio F; Plazzi PV; Bertoni S; Spadoni G; Diamantini G; Bedini A; Tarzia G; Zusso M; Franceschini D; Giusti P
    J Pineal Res; 2004 Mar; 36(2):95-102. PubMed ID: 14962060
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis, antioxidant activity and structure-activity relationships for a new series of 2-(N-acylaminoethyl)indoles with melatonin-like cytoprotective activity.
    Spadoni G; Diamantini G; Bedini A; Tarzia G; Vacondio F; Silva C; Rivara M; Mor M; Plazzi PV; Zusso M; Franceschini D; Giusti P
    J Pineal Res; 2006 Apr; 40(3):259-69. PubMed ID: 16499563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antioxidant and cytoprotective activity of indole derivatives related to melatonin.
    Mor M; Spadoni G; Diamantini G; Bedini A; Tarzia G; Silva C; Vacondio F; Rivara M; Plazzi PV; Franceschini D; Zusso M; Giusti P
    Adv Exp Med Biol; 2003; 527():567-75. PubMed ID: 15206775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel indole-based melatonin analogues: Evaluation of antioxidant activity and protective effect against amyloid β-induced damage.
    Gurer-Orhan H; Karaaslan C; Ozcan S; Firuzi O; Tavakkoli M; Saso L; Suzen S
    Bioorg Med Chem; 2016 Apr; 24(8):1658-64. PubMed ID: 26970662
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and comparison of antioxidant properties of indole-based melatonin analogue indole amino Acid derivatives.
    Suzen S; Cihaner SS; Coban T
    Chem Biol Drug Des; 2012 Jan; 79(1):76-83. PubMed ID: 21883955
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mapping the melatonin receptor. 6. Melatonin agonists and antagonists derived from 6H-isoindolo[2,1-a]indoles, 5,6-dihydroindolo[2,1-a]isoquinolines, and 6,7-dihydro-5H-benzo[c]azepino[2,1-a]indoles.
    Faust R; Garratt PJ; Jones R; Yeh LK; Tsotinis A; Panoussopoulou M; Calogeropoulou T; Teh MT; Sugden D
    J Med Chem; 2000 Mar; 43(6):1050-61. PubMed ID: 10737738
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NO-donor melatonin derivatives: synthesis and in vitro pharmacological characterization.
    Chegaev K; Lazzarato L; Rolando B; Marini E; Tosco P; Cena C; Fruttero R; Bertolini F; Reist M; Carrupt PA; Lucini V; Fraschini F; Gasco A
    J Pineal Res; 2007 Apr; 42(4):371-85. PubMed ID: 17439554
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The anti-oxidant effects of melatonin derivatives on human gingival fibroblasts.
    Phiphatwatcharaded C; Puthongking P; Chaiyarit P; Johns NP; Sakolchai S; Mahakunakorn P
    Arch Oral Biol; 2017 Jul; 79():55-61. PubMed ID: 28292674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemical and physical properties and potential mechanisms: melatonin as a broad spectrum antioxidant and free radical scavenger.
    Tan DX; Reiter RJ; Manchester LC; Yan MT; El-Sawi M; Sainz RM; Mayo JC; Kohen R; Allegra M; Hardeland R
    Curr Top Med Chem; 2002 Feb; 2(2):181-97. PubMed ID: 11899100
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new melatonin receptor ligand with mt1-agonist and MT2-antagonist properties.
    Nonno R; Lucini V; Spadoni G; Pannacci M; Croce A; Esposti D; Balsamini C; Tarzia G; Fraschini F; Stankov BM
    J Pineal Res; 2000 Nov; 29(4):234-40. PubMed ID: 11068946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and antioxidant activity evaluations of melatonin-based analogue indole-hydrazide/hydrazone derivatives.
    Yılmaz AD; Coban T; Suzen S
    J Enzyme Inhib Med Chem; 2012 Jun; 27(3):428-36. PubMed ID: 21740102
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel indole-based analogs of melatonin: synthesis and in vitro antioxidant activity studies.
    Shirinzadeh H; Eren B; Gurer-Orhan H; Suzen S; Ozden S
    Molecules; 2010 Mar; 15(4):2187-202. PubMed ID: 20428037
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New indole-7-aldehyde derivatives as melatonin analogues; synthesis and screening their antioxidant and anticancer potential.
    Shirinzadeh H; Neuhaus E; Ince Erguc E; Tascioglu Aliyev A; Gurer-Orhan H; Suzen S
    Bioorg Chem; 2020 Nov; 104():104219. PubMed ID: 32916391
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro and in vivo assessment of the antioxidant activity of melatonin and related indole derivatives.
    Stetinová V; Smetanová L; Grossmann V; Anzenbacher P
    Gen Physiol Biophys; 2002 Jun; 21(2):153-62. PubMed ID: 12236544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of melatonin and melatonin receptors ligand N-[(4-methoxy-1H-indol-2-yl)methyl]propanamide on murine Colon 38 cancer growth in vitro and in vivo.
    Winczyk K; Pawlikowski M; Lawnicka H; Kunert-Radek J; Spadoni G; Tarzia G; Karasek M
    Neuro Endocrinol Lett; 2002 Apr; 23 Suppl 1():50-4. PubMed ID: 12019352
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Melatonin analogue new indole hydrazide/hydrazone derivatives with antioxidant behavior: synthesis and structure-activity relationships.
    Gürkök G; Coban T; Suzen S
    J Enzyme Inhib Med Chem; 2009 Apr; 24(2):506-15. PubMed ID: 18972245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel indole-based melatonin analogues substituted with triazole, thiadiazole and carbothioamides: studies on their antioxidant, chemopreventive and cytotoxic activities.
    Shirinzadeh H; Ince E; Westwell AD; Gurer-Orhan H; Suzen S
    J Enzyme Inhib Med Chem; 2016 Dec; 31(6):1312-21. PubMed ID: 26745200
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 1-(2-Alkanamidoethyl)-6-methoxyindole derivatives: a new class of potent indole melatonin analogues.
    Tarzia G; Diamantini G; Di Giacomo B; Spadoni G; Esposti D; Nonno R; Lucini V; Pannacci M; Fraschini F; Stankov BM
    J Med Chem; 1997 Jun; 40(13):2003-10. PubMed ID: 9207941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A high concentration of melatonin inhibits in vitro LDL peroxidation but not oxidized LDL toxicity toward cultured endothelial cells.
    Walters-Laporte E; Furman C; Fouquet S; Martin-Nizard F; Lestavel S; Gozzo A; Lesieur D; Fruchart JC; Duriez P; Teissier E
    J Cardiovasc Pharmacol; 1998 Oct; 32(4):582-92. PubMed ID: 9781926
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the structure-activity relationships of melatonin receptor agonists and antagonists: lengthening the N-acyl side-chain has differing effects on potency on Xenopus melanophores.
    Teh MT; Sugden D
    Naunyn Schmiedebergs Arch Pharmacol; 1998 Nov; 358(5):522-8. PubMed ID: 9840420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.